Veeva Systems (VEEV) concluded the recent trading session at $213.68, signifying a +0.15% move from its prior day's close.
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
VEEV's robust product portfolio raises optimism about the stock. However, stiff competition and escalating costs are concerning.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
In the latest trading session, Veeva Systems (VEEV) closed at $236.87, marking a +0.8% move from the previous day.
Veeva (VEEV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Veeva Systems (VEEV) closed at $212.78 in the latest trading session, marking a +1.89% move from the prior day.
VEEV partners with Walgreens to provide better patient outcomes to life sciences companies.
Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
VEEV's robust product portfolio raises optimism about the stock. However, escalating costs are concerning.
The latest trading day saw Veeva Systems (VEEV) settling at $212.23, representing a -0.18% change from its previous close.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.